Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery

The Long Run with Luke Timmerman - A podcast by Timmerman Report

Podcast artwork

Tariq Kassum, CEO of Cambridge, Mass.-based Celsius Therapeutics, on using single cell technology for drug discovery.